National Institute on Drug Abuse; Amended Notice of Meeting, 34259 [2024-09260]

Download as PDF Federal Register / Vol. 89, No. 84 / Tuesday, April 30, 2024 / Notices Contact Person: Andrea B. Kelly, Ph.D., Scientific Review Officer, National Institute on Deafness and Other Communication Disorders, National Institutes of Health, 6001 Executive Boulevard, Room 8351, Bethesda, MD 20892, (301) 451–6339, kellya2@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.173, Biological Research Related to Deafness and Communicative Disorders, National Institutes of Health, HHS) Dated: April 24, 2024. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–09180 Filed 4–29–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Aging; Notice of Closed Meeting lotter on DSK11XQN23PROD with NOTICES1 Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Institute on Aging Special Emphasis Panel; NIA IMPACT Collaboratory. Date: June 7, 2024. Time: 12:00 p.m. to 3:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute on Aging, Gateway Building, 7201 Wisconsin Avenue, Bethesda, MD 20892 (Virtual Meeting). Contact Person: Sandhya Sanghi, Ph.D., Scientific Review Officer, National Institutes of Health,National Institute on Aging, Gateway Building, 7201 Wisconsin Avenue (2N230), NIA/SRB, Bethesda, MD 20892, (301) 496–2879, sandhya.sanghi@nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging Research, National Institutes of Health, HHS) Dated: April 25, 2024. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–09261 Filed 4–29–24; 8:45 am] BILLING CODE 4140–01–P VerDate Sep<11>2014 17:27 Apr 29, 2024 Jkt 262001 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 1009 of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Allergy, Immunology, and Transplantation Research Committee. Date: June 20–21, 2024. Time: 10:00 a.m. to 6:00 p.m. Agenda: To review and evaluate grant applications. Place: National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G51, Rockville, MD 20892 (Virtual). Contact Person: Thomas F. Conway, Ph.D., Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institute of Allergy and Infectious Diseases, National Institutes of Health, 5601 Fishers Lane, Room 3G51, Rockville, MD 20892, 240–507–9685, thomas.conway@ nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: April 25, 2024. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–09302 Filed 4–29–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Drug Abuse; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the National Advisory Council on Drug Abuse, May 07, 2024, 10:30 a.m. to May 07, 2024, 05:00 p.m., National Institutes of Health, Neuroscience Center, 6001 Executive PO 00000 Frm 00063 Fmt 4703 Sfmt 4703 34259 Boulevard, Rockville, MD 20852 which was published in the Federal Register on March 28, 2024, FR Doc. 2024– 06612, 89 FR 21526. This notice is being amended to change the open session start and end time from 12:45 p.m.–05:00 p.m. to 01:00 p.m.–4:45 p.m. The meeting date, closed session time, and location will stay the same. The meeting is partially closed to the public. Dated: April 25, 2024. Miguelina Perez, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2024–09260 Filed 4–29–24; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Office of the Secretary, Muscular Dystrophy Coordinating Committee Call for Committee Membership Nominations AGENCY: National Institutes of Health, HHS. ACTION: Notice. The Office of the Secretary of the Department of Health and Human Services (HHS) is seeking nominations for one individual to serve as a nonFederal public member on the Muscular Dystrophy Coordinating Committee. DATES: Nominations are due by 5:00 p.m. ET on May 31, 2024. ADDRESSES: Nominations must be sent to Glen Nuckolls, Ph.D., by email to nuckollg@ninds.nih.gov. FOR FURTHER INFORMATION CONTACT: Glen Nuckolls, Ph.D., by email to nuckollg@ ninds.nih.gov or (301) 496–5745. SUPPLEMENTARY INFORMATION: The Muscular Dystrophy Coordinating Committee (MDCC) is a Federal advisory committee established in accordance with the Muscular Dystrophy Community Assistance, Research, and Education Amendments of 2001 (MD–CARE Act; Pub. L. 107– 84). The MD–CARE Act was reauthorized in 2008 by Public Law 110–361, and again in 2014 by Public Law 113–166. The MD–CARE Act specifies that the committee membership be composed of 2⁄3 governmental agency representatives and 1⁄3 public members. We are seeking nominations for one non-Federal public member at this time, due to turnover of committee membership. Nominations will be accepted until 5:00 p.m. ET on May 31, 2024. SUMMARY: E:\FR\FM\30APN1.SGM 30APN1

Agencies

[Federal Register Volume 89, Number 84 (Tuesday, April 30, 2024)]
[Notices]
[Page 34259]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2024-09260]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Institute on Drug Abuse; Amended Notice of Meeting

    Notice is hereby given of a change in the meeting of the National 
Advisory Council on Drug Abuse, May 07, 2024, 10:30 a.m. to May 07, 
2024, 05:00 p.m., National Institutes of Health, Neuroscience Center, 
6001 Executive Boulevard, Rockville, MD 20852 which was published in 
the Federal Register on March 28, 2024, FR Doc. 2024-06612, 89 FR 
21526.
    This notice is being amended to change the open session start and 
end time from 12:45 p.m.-05:00 p.m. to 01:00 p.m.-4:45 p.m. The meeting 
date, closed session time, and location will stay the same. The meeting 
is partially closed to the public.

    Dated: April 25, 2024.
Miguelina Perez,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2024-09260 Filed 4-29-24; 8:45 am]
BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.